SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-022333
Filing Date
2019-04-30
Accepted
2019-04-30 15:10:22
Documents
6
Period of Report
2019-06-19
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv519503-def14a.htm DEF 14A 358048
2 GRAPHIC lg_avenue-thera.jpg GRAPHIC 97742
3 GRAPHIC sg_joseph-vazzano.jpg GRAPHIC 18852
4 GRAPHIC sg_lucy-lu.jpg GRAPHIC 16516
5 GRAPHIC tv519503_pc1.jpg GRAPHIC 533955
6 GRAPHIC tv519503_pc2.jpg GRAPHIC 430233
  Complete submission text file 0001144204-19-022333.txt   1870700
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38114 | Film No.: 19781007
SIC: 2834 Pharmaceutical Preparations